Laíse Taciane Rodrigues Jardim

Dr. Laíse Taciane Rodrigues Jardim

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2025 in Environments
Verified
Journal Article
Open access
PDF file
GSGabriel Souza-Silva
Gabriel Souza-Silva
VBValéria Aparecida Bispo
Valéria Aparecida Bispo
MMMariângela Domingos Alcântara Mari
Mariângela Domingos Alcântara Mari
MSMaria Clara Starling
Maria Clara Starling
CSCléssius Ribeiro de Souza
Cléssius Ribeiro de Souza
MSMicheline Rosa Silveira
Micheline Rosa Silveira
Antiretrovirals (ARVs) present variable toxicity to aquatic organisms. This study reviewed the literature from the Web of Science, Scopus, and PubMed to evaluate ARV ecotoxicity, focusing on aquatic models. Inclusion criteria were studies using ARVs as test substances with toxicity data on aquatic organisms. Quality assessment followed the CRED method, and environmental risk was evaluated via risk quotients (RQs) using the ERA tool. Efavirenz emerged as the most toxic ARV, with EC50 values of 0.011 mg/L (Chlorococcum infusionum) to 0.034 mg/L (Raphidocelis subcapitata), causing growth inhibition, photosynthesis reduction, and oxidative stress. Tenofovir showed lower toxicity, with EC50 values above 300.0 mg/L (Biomphalaria glabrata) and 111.82 mg/L (Artemia salina). Other ARVs, including Lamivudine and Zidovudine, displayed moderate toxicity (EC50 3.013–5.442 mg/L in microalgae). Main effects observed included oxidative damage, altered enzyme activity (catalase and NADH-cytochrome C oxidoreductase), reduced growth and photosynthesis, and bioaccumulation in aquatic plants like Lemna minor. Efavirenz also showed synergistic toxicity when combined with other ARVs. These findings indicate that ARVs, particularly highly toxic compounds such as Efavirenz, pose significant ecological risks, emphasizing the importance of proper disposal and remediation strategies to protect aquatic ecosystems.

GSGabriel Souza-Silva
Gabriel Souza-Silva
MMMatheus Miranda
Matheus Miranda
ISIgor Francisco Chagas dos Santos
Igor Francisco Chagas dos Santos
LJLaíse Taciane Rodrigues Jardim
Laíse Taciane Rodrigues Jardim
CSCléssius R. Souza
Cléssius R. Souza
MSMicheline Rosa Silveira
Micheline Rosa Silveira
This study investigates the ecopharmacodynamics of antiretrovirals (ARVs) through an integrated cyclic model that correlates population consumption, environmental fate, and human re-exposure. In the assessed scenario, incomplete excretion introduces approximately 6.5 × 104 kg/year of unchanged drugs into sewage, led by darunavir (1.8 × 104 kg/year) and tenofovir disoproxil (1.0 × 104 kg/year). The ineffectiveness of conventional treatment plants (average removal of 59.8%) allows substantial fractions to reach water bodies or to partition strongly into residual sludge, reaching concentrations of 314 ng/g for zidovudine and 299 ng/g for lamivudine. In surface waters, elevated levels of nevirapine (81.1 µg/L) and lamivudine (30.2 µg/L) are observed, accompanied by significant sedimentary accumulation (zidovudine at 314 ng/g). Crucially, drinking water treatment systems prove unable to retain these compounds, culminating in the presence of abacavir (2.9 × 103 ng/L) and atazanavir (2.7 × 103 ng/L) in the drinking water supplied to the population. These data confirm that ARVs do not disappear after consumption but operate in an open anthropo-circulatory circuit, in which continuous water intake perpetually reinitiates human exposure, requiring advanced polishing technologies and One Health surveillance.